(Q33330951)

25 July 2017

A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response (English)

1 reference

25 July 2017

0 references

11

Y Shoenfeld

1 reference

25 July 2017

1

Y Levy

1 reference

25 July 2017

2

Y Sherer

1 reference

25 July 2017

4

P Langevitz

1 reference

25 July 2017

5

J George

1 reference

25 July 2017

A Ahmed

3

1 reference

25 July 2017

F Fabbrizzi

6

1 reference

25 July 2017

J Terryberry

7

1 reference

25 July 2017

M Meissner

8

1 reference

25 July 2017

M Lorber

9

1 reference

25 July 2017

J B Peter

10

1 reference

25 July 2017

1 January 1999

1 reference

25 July 2017

1 reference

25 July 2017

8

1 reference

25 July 2017

705-712

1 reference

25 July 2017

9

1 reference

The effect of intravenous gamma-globulin on the induction of experimental antiphospholipid syndrome

25 July 2017

1 reference

https://api.crossref.org/works/10.1191%2F096120399678841007

New methods of treatment in an experimental murine model of systemic lupus erythematosus induced by idiotypic manipulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678841007

High-dose intravenous gamma-globulins for heparin-induced thrombocytopenia: a prompt response

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678841007

Improvement of histological and immunological change in steroid and immunosuppressive drug-resistant lupus nephritis by high-dose intravenous gamma globulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678841007

The 1982 revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678841007

Detection of anti-dsDNA as a diagnostic tool: a prospective study in 441 non-systemic lupus erythematosus patients with anti-dsDNA antibody (anti-dsDNA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678841007

Recurrent cerebral infarction and the antiphospholipid syndrome: effect of intravenous gammaglobulin in a patient with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678841007

Prolonged remission of SLE-associated polyradiculoneuropathy after a single course of intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678841007

Successful treatment of systemic lupus erythematosus cerebritis with intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678841007

Effect of intravenous immunoglobulin on steroid consumption in patients with severe asthma: a double-blind, placebo-controlled, randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678841007

Anti-DNA and antiphospholipid antibodies in IVIG preparations: in vivo study in naive mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678841007

Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678841007

High-dose intravenous IgG treatment and renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678841007

Intravenous gamma-globulin therapy in systemic lupus erythematosus and immune complex disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678841007

Comparison of the efficacy of a two-day and a five-day schedule for infusing intravenous gamma globulin in the treatment of immune thrombocytopenic purpura in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678841007

Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120399678841007

10.1191/096120399678841007

21 January 2018

Identifiers

DOI

1 reference

25 July 2017

1 reference